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ABSTRACT
Objective To estimate the 6-year radiographic progression
of sacroiliitis in patients with early spondyloarthritis (SpA).
Patients and methods Sacroiliac joint (SIJ) radiographs
(baseline and 6 years) of 94 patients with recent-onset SpA
from the Esperanza cohort were scored, blindly and in
a random order, by nine readers. The modified New York
criteria were used to define the presence of sacroiliitis. As
the gold standard for radiographic (r) sacroiliitis, the
categorical opinion of at least five readers was used.
Progression was defined as the shift from non-radiographic
(nr) to r-sacroiliitis.
Results In the 94 SIJ radiographs (baseline and 6 years),
78/94 (83%) pairs of radiographs had not changed from
baseline to 6 years. Sacroiliitis was present in 20 patients at
baseline (21.3%) and in 18 (19.2%) patients at 6 years; 11
patients had sacroiliitis at both the baseline and final visits;
9 patients changed from baseline r-sacroiliitis to nr-
sacroiliitis at 6 years, and 7 changed from baseline nr-
sacroiliitis to r-sacroiliitis at 6 years. The mean continuous
change score (range: −8 to +8) was 2.80 at baseline and
2.55 at 6 years (mean net progression of −0.25). The
reliability of the readers was fair (mean inter-reader kappa
of 0.375 (0.146–0.652) and mean agreement of 73.7%
(58.7–90%)).
Conclusion In the early SpA Esperanza cohort, progression
from nr-axSpA to r-axSpA over 6 years was not observed,
although the SIJ radiographs scoring has limitations to
detect low levels of radiographic progression.
INTRODUCTION
Radiographic assessment of the sacroiliac
joints (SIJ) plays an important role in the
diagnosis of patients with axial spondyloar-
thritis (axSpA) as well as in their
classification.1 Definite radiographic (r)
sacroiliitis (at least a bilateral grade 2 or
a unilateral grade 3 or 4) is a requirement
for making the diagnosis of ankylosing spon-
dylitis (AS) according to the modified
New York (mNY) criteria2 and is also
a cornerstone in the image arm of the Assess-
ment of SpondyloArthritis international
Society (ASAS) axial classification criteria.1
Thus, patients with axSpA are currently
divided into two groups: those with r-axSpA
or AS, with radiographic damage of the SIJ
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What is already known about this subject?
► A recent review disclosed that approximately 10–40%
of the patients with nr-axSpA progress to r-axSpA over
a period of 2–10 years. However, some early cohorts
have shown progression rates of about 5% at 5 years.
What does this study add?
► In the early SpA Esperanza cohort, progression from
nr-axSpA to r-axSpA over 6 years was not observed.
We had a low net change of −0.25, which is below
clinically relevant change and probably can be
attributed to the measurement error.
How might this impact on clinical practice?
► Recent studies on early SpA cohorts show less
radiographic progression than the reported in classical
cohorts. If this is the case, an increase in the prevalence
of nr-axSpA would be expected. To deepen the
knowledge about the evolution of the patients with
early SpA, we would ought to improve the assessment
of SIJ damage and also ascertain whether early
diagnosis delays radiographic progression.
Spondyloarthritis
Fernández-Carballido C, et al. RMD Open 2020;6:e001345. doi:10.1136/rmdopen-2020-001345 1
 on F










pen: first published as 10.1136/rm






(fulfilling X-ray mNY criteria); and those with non-
radiographic axSpA (nr-axSpA), defined by the absence
of definite r-sacroiliitis. Conventional radiography of the
SIJ is the first recommended imaging method when
axSpA is suspected, according to the EULAR
recommendations.3 However, the complex anatomy of
the SIJ makes the interpretation of conventional radio-
graphs challenging, and sacroiliitis recognition can be
difficult. In this regard, several studies have consistently
shown large inter-observer variability among trained
readers4–6 and between central and local readers6 and
no improvement after training.7 A proportion of patients
with nr-axSpA might never develop definite radiographic
damage, whereas others will experience a shift from nr-
axSpA to r-axSpA.8 The celerity of this shift and its pre-
disposing factors are still unclear,9 10 and data on recent-
onset SpA cohorts are scarce. In this sense, our main
objective was to evaluate the rate of SIJ radiographic
progression in patients with recent-onset SpA (<2 years
since onset of symptoms).
METHODS
We evaluated the SIJ radiographs of patients from the
Esperanza Program, a Spanish prospective national
health initiative intended to facilitate the early diagnosis
and follow-up of patients with SpA. Details of this Pro-
gram have been previously published.11 In summary,
patients eligible for inclusion were 18–45 years of age;
had symptom duration between 3 and 24 months; and
were experiencing inflammatory back pain, asymmetrical
arthritis, or spinal or joint pain plus one SpA feature. The
Program protocol was approved by the Research Ethics
Committee of Hospital Reina Sofía, Córdoba, Spain. For
the current study, 292 SIJ radiographs were used for the
reliability study, of which 94 pairs (baseline and 6 years)
were available for the radiographic progression study. All
radiographs were scored by nine readers, blinded for
time order and clinical data. All readers were experi-
enced rheumatologists and members of the Spanish
spondyloarthritis working group (GRESSER). All pairs
(baseline and 6 years) of SIJ radiographs were evaluated
as specified in the mNY criteria3 and graded accordingly
(from 0 to 4). Thus, r-sacroiliitis was defined if at least
a bilateral grade 2 or a unilateral grade 3 or 4 was present.
The categorical opinion for positive r-sacroiliitis by at
least five readers was considered the gold standard.
STATISTICS
We determined the proportion of ‘progressors’ (% of
patients with worsening) as well as the proportion of
‘regressors’ (% of patients with improvement). Progres-
sion was defined as the shift from non-radiographic (nr)-
to r-sacroiliitis and regression as the switch from r-sacroi-
liitis to nr-sacroiliitis at 6 years. In addition, ‘net’ percen-
tage of progression was defined as the number of
‘progressors’ minus the number of ‘regressors’ divided
by the total number of the study population.12 Also, the
continuous change score was calculated (range: −8 to +8),
where a negative value means the mNY grade at 6 years is
lower than the grade at baseline.13 Inter-reader reliability
was calculated by the Cohen’s kappa value and agreement
among the readers.
RESULTS
Radiographic progression of the SIJ was evaluated at 6 years
in 94 pairs of radiographs. The baseline characteristics of
the 94 patients whose radiographs were scored were as
follows: 50 patients (53.2%) were male; mean (SD) age
was 34 (7.5) years (range: 18–45 years); HLA-B27 was posi-
tive in 39 patients (41.5%) andmissing in 1patient (1.06%);
27.9% of the patients were present smokers, 21.3% ex-
smokers (stopped more than one year before the study)
and 50.8% never smoked; mean (SD) levels of C reactive
protein and erythrocyte sedimentation rate were 4.96
(6.54) mg/L and 11.31 (11.84) mm/hour, respectively.
Regarding the presence of r-sacroiliitis, at baseline, it
was present in 20/94 (21.3%) patients, and at 6 years, it
was present in 18/94 (19.2%) patients. In total, 78/94
(83%) pairs of radiographs had not changed from base-
line to 6 years, with 11 (11.7%) pairs of radiographs
showing sacroiliitis at both baseline and 6 years and 67
(71.3%) pairs of radiographs not showing sacroiliitis at
baseline and 6 years. Regarding the changes in sacroiliitis
status (binary), 16/94 (17%) pairs changed in 6 years,
with 7 (7.5%) shifting from negative to positive at 6 years
and 9 (9.6%) that were positive at baseline being negative
at 6 years (net change of −0.02). The mean continuous
change score (range: −8 to +8) was 2.80 at baseline and
2.55 at 6 years, with a mean net progression of −0.25.
The results of the reliability study in terms of the degree
of agreement among the readers and kappa values are
depicted in table 1. The mean kappa achieved was fair at
0.375 (range: 0.146–0.652), and the mean agreement was
73.66% (range: 58.68– 89.93%). Larger discrepancies
were observed when assessing grade 2 sacroiliitis.
DISCUSSION
Longitudinal studies about the change from non-
radiographic axial spondyloarthritis (nr-axSpA) to radio-
graphic axial spondyloarthritis (r-axSpA) have shown
rates of 10–12% progression over 2 years5 14 and a recent
review disclosed a progression rate of 10–40% over
a period of 2–10 years.9 We have shown a small but nega-
tive ‘net’ progression that, given the early nature of the
cohort (patients with a disease duration <2 years), would
suggest no progression. The reported ‘net’ progression in
the DESIR10 and ASAS15 cohorts was 5.1% at 5 years and
5% at 4.4 years of follow-up, respectively. At first glance, it
would seem that recent studies are detecting less SIJ
radiographic progression than the classical ones. How-
ever, the quantification of radiographic progression is
susceptible to measurement error and, together with the
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limited reliability of the SIJ radiograph scoring, might be
the most likely reason for the absence of radiographic
progression of the SIJ in our cohort, where the ‘regres-
sors’ outweigh the ‘progressors’ and change over-and-
above measurement error was not detected. Relatively
high regression rates of r-sacroiliitis over time have been
disclosed in other studies.5 9 15 16 For example, cross-
tabulation of the results of the ASAS cohort revealed
that more than half of the mNY-positive at baseline were
mNY-negative at follow-up,15 pointing out that the inter-
pretation of progression, regression and measurement
error might not be easily unravelled. In this sense, some
authors have proposed a new approach, the ‘assumption-
free net progression’.13 Moreover, the limitations of the
scoring of the SIJ radiographs in terms of reliability are
known, especially in early stages of the disease.4–6 16–18We
disclosed a fair level of agreement between the readers
(mean kappa value of 0.375) and a mean agreement of
73.7%, in line with a reported mean kappa value of 0.39
and agreement of 84.1% in 104 consecutive patients with
low back pain ≥3 months of duration who met the ASAS
definition for a positive SIJ magnetic resonance image or
HLA-B27–positive arms.17 Regarding reliability, other
studies have disclosed results from fair to moderate4–6
and no improvement after training.7 Furthermore, even
central readers have only moderate agreement on the
grade of sacroiliitis.18 Also, what is especially challenging
is accurately detecting early or minimal abnormalities
within the SI joint, particularly grades 1 and 2 on the
mNY scoring scale,7 19 as it happened in our study.
Although we acknowledge that the limitations in the
rating of the SIJ radiographs might have influenced the
results, conventional radiography of the SIJ is still the first
recommended imaging method for suspicion of axSpA3
and to evaluate sacroiliitis progression.
Another question is whether the predominance of nr-
axSpA (78.7% of the patients with paired radiographs
available in our study) could also result in lower global
rates of progression. Theoretically, this might be another
possible explanation, but a study disclosed that patients
with nr-axSpA showed even more progression (10.5%)
than those with AS (4.4%).5 In addition, in a study of
the same cohort, patients with nr-axSpA and AS not trea-
ted with tumour necrosis factor blockers demonstrated
a similar clinical disease course over 2 years.20
Last, another plausible explanation would be that early
diagnosis and treatment may confer a ‘window of opportu-
nity’ for patients with axSpA. Nonetheless, the design and
results of our study prevent us from confirming this
hypothesis.
In summary, in this group of patients with early SpA, no
progression from nr-axSpA to r-axSpA over 6 years was
observed. The limitations in the rating of the SIJ radio-
graphs might impede the detection of low levels of radio-
graphic progression, especially in early cohorts of axSpA.
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